4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083607
Options or other derivatives
- General Counsel acquired 16,385 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Murdock Hunter R. General Counsel | 2026-02-26 | Grant or award · Restricted Stock Units | +16,385 | 16,385 | D | ||
Loading xslF345X05/ownership.xml…